Maria A. Aznar

Pamplona, NC 31008, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Dual-targeted ping-pong CAR T cells: Leveraging peripheral expansion to improve solid tumor immunotherapy.

Dual-targeted ping-pong CAR T cells: Leveraging peripheral expansion to improve solid tumor immunotherapy.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: December 15, 2025

IL-9 signaling redirects CAR T cell fate toward CD8+ memory and CD4+ cycling states, enhancing antitumor efficacy.

IL-9 signaling redirects CAR T cell fate toward CD8+ memory and CD4+ cycling states, enhancing antitumor efficacy.

Journal: Immunity

Published: January 17, 2025

Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer.

Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer.

Journal: Cell reports. Medicine

Published: November 15, 2024

Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells.

Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells.

Journal: Immunity

Published: August 09, 2022

An NK-like CAR T cell transition in CAR T cell dysfunction.

An NK-like CAR T cell transition in CAR T cell dysfunction.

Journal: Cell

Published: November 04, 2020

Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors.

Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors.

Journal: Science translational medicine

Published: January 24, 2020

Repurposing the yellow fever vaccine for intratumoral immunotherapy.

Repurposing the yellow fever vaccine for intratumoral immunotherapy.

Journal: EMBO molecular medicine

Published: January 25, 2019

Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+ T Cells.

Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+ T Cells.

Journal: Cancer cell

Published: December 22, 2018

For Whom the Cell Tolls? Intratumoral Treatment Links Innate and Adaptive Immunity.

For Whom the Cell Tolls? Intratumoral Treatment Links Innate and Adaptive Immunity.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 03, 2018

Immunotherapeutic effects of intratumoral nanoplexed poly I:C.

Immunotherapeutic effects of intratumoral nanoplexed poly I:C.

Journal: Journal for immunotherapy of cancer

Published: July 07, 2018

Cytokines in clinical cancer immunotherapy.

Cytokines in clinical cancer immunotherapy.

Journal: British journal of cancer

Published: June 19, 2018

A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity.

A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity.

Journal: Nature communications

Published: June 05, 2018

Showing 1-12 of 31

Last Updated: 09/26/2026